Titre : Xanthènes

Xanthènes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Case-Control Studies
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Xanthènes : Questions médicales les plus fréquentes", "headline": "Xanthènes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Xanthènes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-07", "dateModified": "2025-05-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Xanthènes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composés hétérocycliques 3 noyaux", "url": "https://questionsmedicales.fr/mesh/D006575", "about": { "@type": "MedicalCondition", "name": "Composés hétérocycliques 3 noyaux", "code": { "@type": "MedicalCode", "code": "D006575", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Propanthéline", "alternateName": "Propantheline", "url": "https://questionsmedicales.fr/mesh/D011413", "about": { "@type": "MedicalCondition", "name": "Propanthéline", "code": { "@type": "MedicalCode", "code": "D011413", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.558" } } }, { "@type": "MedicalWebPage", "name": "Pyronine", "alternateName": "Pyronine", "url": "https://questionsmedicales.fr/mesh/D011754", "about": { "@type": "MedicalCondition", "name": "Pyronine", "code": { "@type": "MedicalCode", "code": "D011754", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.570" } } }, { "@type": "MedicalWebPage", "name": "Rhodamines", "alternateName": "Rhodamines", "url": "https://questionsmedicales.fr/mesh/D012235", "about": { "@type": "MedicalCondition", "name": "Rhodamines", "code": { "@type": "MedicalCode", "code": "D012235", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.600" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Rhodamine 123", "alternateName": "Rhodamine 123", "url": "https://questionsmedicales.fr/mesh/D020112", "about": { "@type": "MedicalCondition", "name": "Rhodamine 123", "code": { "@type": "MedicalCode", "code": "D020112", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.600.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Thioxanthènes", "alternateName": "Thioxanthenes", "url": "https://questionsmedicales.fr/mesh/D013892", "about": { "@type": "MedicalCondition", "name": "Thioxanthènes", "code": { "@type": "MedicalCode", "code": "D013892", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chlorprothixène", "alternateName": "Chlorprothixene", "url": "https://questionsmedicales.fr/mesh/D002749", "about": { "@type": "MedicalCondition", "name": "Chlorprothixène", "code": { "@type": "MedicalCode", "code": "D002749", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704.250" } } }, { "@type": "MedicalWebPage", "name": "Clopenthixol", "alternateName": "Clopenthixol", "url": "https://questionsmedicales.fr/mesh/D003006", "about": { "@type": "MedicalCondition", "name": "Clopenthixol", "code": { "@type": "MedicalCode", "code": "D003006", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704.269" } } }, { "@type": "MedicalWebPage", "name": "Flupentixol", "alternateName": "Flupenthixol", "url": "https://questionsmedicales.fr/mesh/D005475", "about": { "@type": "MedicalCondition", "name": "Flupentixol", "code": { "@type": "MedicalCode", "code": "D005475", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704.360" } } }, { "@type": "MedicalWebPage", "name": "Hycanthone", "alternateName": "Hycanthone", "url": "https://questionsmedicales.fr/mesh/D006826", "about": { "@type": "MedicalCondition", "name": "Hycanthone", "code": { "@type": "MedicalCode", "code": "D006826", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704.450" } } }, { "@type": "MedicalWebPage", "name": "Tiotixène", "alternateName": "Thiothixene", "url": "https://questionsmedicales.fr/mesh/D013888", "about": { "@type": "MedicalCondition", "name": "Tiotixène", "code": { "@type": "MedicalCode", "code": "D013888", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704.787" } } } ] }, { "@type": "MedicalWebPage", "name": "Xanthones", "alternateName": "Xanthones", "url": "https://questionsmedicales.fr/mesh/D044004", "about": { "@type": "MedicalCondition", "name": "Xanthones", "code": { "@type": "MedicalCode", "code": "D044004", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.852" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lucanthone", "alternateName": "Lucanthone", "url": "https://questionsmedicales.fr/mesh/D008154", "about": { "@type": "MedicalCondition", "name": "Lucanthone", "code": { "@type": "MedicalCode", "code": "D008154", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.852.388" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Xanthènes", "alternateName": "Xanthenes", "code": { "@type": "MedicalCode", "code": "D014966", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hongji Li", "url": "https://questionsmedicales.fr/author/Hongji%20Li", "affiliation": { "@type": "Organization", "name": "Key Laboratory of Green and Precise Synthetic Chemistry and Applications, Ministry of Education, School of Chemistry and Materials Science, Huaibei Normal University, Huaibei, Anhui 235000, P. R. China." } }, { "@type": "Person", "name": "Steven R Gwaltney", "url": "https://questionsmedicales.fr/author/Steven%20R%20Gwaltney", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Mississippi State University, Mississippi State, Mississippi 39762, United States." } }, { "@type": "Person", "name": "Colleen N Scott", "url": "https://questionsmedicales.fr/author/Colleen%20N%20Scott", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Mississippi State University, Mississippi State, Mississippi 39762, United States." } }, { "@type": "Person", "name": "Ramalingam Manivannan", "url": "https://questionsmedicales.fr/author/Ramalingam%20Manivannan", "affiliation": { "@type": "Organization", "name": "Department of Advanced Organic Materials Engineering, Chungnam National University, 220 Gung-dong, Yuseong-gu, Daejeon, 305-764, South Korea." } }, { "@type": "Person", "name": "Young-A Son", "url": "https://questionsmedicales.fr/author/Young-A%20Son", "affiliation": { "@type": "Organization", "name": "Department of Advanced Organic Materials Engineering, Chungnam National University, 220 Gung-dong, Yuseong-gu, Daejeon, 305-764, South Korea. yason@cnu.ac.kr." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A case-control study on immunologic markers of patients with vitiligo.", "datePublished": "2022-10-14", "url": "https://questionsmedicales.fr/article/36244264", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.biopha.2022.113785" } }, { "@type": "ScholarlyArticle", "name": "Case-Control Study of Long COVID, Sapporo, Japan.", "datePublished": "2023-04-12", "url": "https://questionsmedicales.fr/article/37044126", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3201/eid2905.221349" } }, { "@type": "ScholarlyArticle", "name": "Endothelium-biomarkers for postthrombotic syndrome: a case-control study.", "datePublished": "2023-03-29", "url": "https://questionsmedicales.fr/article/37016998", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MBC.0000000000001192" } }, { "@type": "ScholarlyArticle", "name": "Risk Factors for Postoperative Pneumonia: A Case-Control Study.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35875004", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2022.913897" } }, { "@type": "ScholarlyArticle", "name": "Significance of temperature in antimuscarinic toxicity: a case-control study.", "datePublished": "2022-06-23", "url": "https://questionsmedicales.fr/article/35735006", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/15563650.2022.2088378" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérocycliques 3 noyaux", "item": "https://questionsmedicales.fr/mesh/D006575" }, { "@type": "ListItem", "position": 5, "name": "Xanthènes", "item": "https://questionsmedicales.fr/mesh/D014966" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Xanthènes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Xanthènes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Xanthènes", "description": "Comment diagnostiquer une intoxication aux xanthènes ?\nQuels tests sont utilisés pour détecter les xanthènes ?\nQuels symptômes indiquent une exposition aux xanthènes ?\nLes xanthènes peuvent-ils être détectés dans l'urine ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Case-Control+Studies&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Xanthènes", "description": "Quels sont les symptômes courants d'une exposition aux xanthènes ?\nLes xanthènes provoquent-ils des réactions allergiques ?\nComment les xanthènes affectent-ils le système nerveux ?\nLes symptômes varient-ils selon le type de xanthène ?\nLes xanthènes affectent-ils la peau ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Case-Control+Studies&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Xanthènes", "description": "Comment prévenir l'exposition aux xanthènes ?\nLes travailleurs doivent-ils être formés sur les xanthènes ?\nQuelles mesures de sécurité doivent être prises en laboratoire ?\nLes xanthènes sont-ils réglementés ?\nComment informer le public sur les dangers des xanthènes ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Case-Control+Studies&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Xanthènes", "description": "Quel traitement est recommandé en cas d'intoxication aux xanthènes ?\nDes antidotes existent-ils pour les xanthènes ?\nComment traiter les symptômes neurologiques causés par les xanthènes ?\nLes soins de soutien sont-ils nécessaires ?\nPeut-on utiliser des traitements naturels contre les xanthènes ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Case-Control+Studies&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Xanthènes", "description": "Quelles complications peuvent survenir après une exposition aux xanthènes ?\nLes xanthènes peuvent-ils causer des maladies chroniques ?\nY a-t-il des effets à long terme des xanthènes ?\nLes xanthènes peuvent-ils affecter la reproduction ?\nComment gérer les complications liées aux xanthènes ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Case-Control+Studies&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Xanthènes", "description": "Qui est le plus à risque d'exposition aux xanthènes ?\nLes enfants sont-ils plus vulnérables aux xanthènes ?\nQuels facteurs environnementaux augmentent le risque ?\nLes antécédents médicaux influencent-ils le risque ?\nLes habitudes de vie jouent-elles un rôle dans le risque ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Case-Control+Studies&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux xanthènes ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les xanthènes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses chromatographiques comme la HPLC sont couramment utilisées." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition aux xanthènes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vertiges et des troubles neurologiques." } }, { "@type": "Question", "name": "Les xanthènes peuvent-ils être détectés dans l'urine ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests urinaires peuvent révéler la présence de xanthènes." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique aide à identifier les expositions antérieures aux xanthènes." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une exposition aux xanthènes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des nausées et des troubles de la vision." } }, { "@type": "Question", "name": "Les xanthènes provoquent-ils des réactions allergiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent développer des réactions allergiques aux xanthènes." } }, { "@type": "Question", "name": "Comment les xanthènes affectent-ils le système nerveux ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des troubles neurologiques comme des convulsions ou des tremblements." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de xanthène ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon la structure chimique des xanthènes." } }, { "@type": "Question", "name": "Les xanthènes affectent-ils la peau ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition cutanée peut entraîner des irritations ou des éruptions." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux xanthènes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les produits contenant des xanthènes et portez des équipements de protection." } }, { "@type": "Question", "name": "Les travailleurs doivent-ils être formés sur les xanthènes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur les risques et la manipulation sécurisée est essentielle." } }, { "@type": "Question", "name": "Quelles mesures de sécurité doivent être prises en laboratoire ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez des hottes, des gants et des lunettes de protection lors de la manipulation." } }, { "@type": "Question", "name": "Les xanthènes sont-ils réglementés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, leur utilisation est souvent réglementée pour protéger la santé publique." } }, { "@type": "Question", "name": "Comment informer le public sur les dangers des xanthènes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes de sensibilisation et des brochures d'information peuvent être utiles." } }, { "@type": "Question", "name": "Quel traitement est recommandé en cas d'intoxication aux xanthènes ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut l'élimination de l'exposition et des soins symptomatiques." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les xanthènes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas d'antidote spécifique pour les xanthènes." } }, { "@type": "Question", "name": "Comment traiter les symptômes neurologiques causés par les xanthènes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments anticonvulsivants peuvent être utilisés pour gérer les symptômes." } }, { "@type": "Question", "name": "Les soins de soutien sont-ils nécessaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des soins de soutien sont souvent nécessaires pour les cas graves." } }, { "@type": "Question", "name": "Peut-on utiliser des traitements naturels contre les xanthènes ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de preuves solides pour des traitements naturels efficaces." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une exposition aux xanthènes ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques et dermatologiques peuvent se développer." } }, { "@type": "Question", "name": "Les xanthènes peuvent-ils causer des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition prolongée peut augmenter le risque de maladies chroniques." } }, { "@type": "Question", "name": "Y a-t-il des effets à long terme des xanthènes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets à long terme incluent des troubles cognitifs et des problèmes de santé." } }, { "@type": "Question", "name": "Les xanthènes peuvent-ils affecter la reproduction ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent qu'ils peuvent avoir des effets néfastes sur la reproduction." } }, { "@type": "Question", "name": "Comment gérer les complications liées aux xanthènes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et des traitements symptomatiques sont recommandés." } }, { "@type": "Question", "name": "Qui est le plus à risque d'exposition aux xanthènes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs dans l'industrie chimique et les laboratoires sont les plus à risque." } }, { "@type": "Question", "name": "Les enfants sont-ils plus vulnérables aux xanthènes ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus sensibles aux effets toxiques des xanthènes." } }, { "@type": "Question", "name": "Quels facteurs environnementaux augmentent le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "La pollution et l'exposition à des produits chimiques augmentent le risque." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies respiratoires ou neurologiques augmentent le risque." } }, { "@type": "Question", "name": "Les habitudes de vie jouent-elles un rôle dans le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme peuvent augmenter la vulnérabilité aux xanthènes." } } ] } ] }

Sources (10000 au total)

Endothelium-biomarkers for postthrombotic syndrome: a case-control study.

The postthrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT). Increase knowledge on the PTS pathophysiology and novel biomarkers are needed in order to predict PTS dev... A case-control study was conducted. Inclusion criteria were symptomatic and confirmed DVT patients treated with anticoagulants for at least 3 months. Villalta score was performed at the time of inclus... Thirty two patients and 61 controls were included. PTS patients showed higher levels of CEC (0.56/μl (0.34-1.5) vs. 0.20/μl (0.11-0.77); P = 0.04) and EPC (0.75/μl (0.38-1.52) vs. 0.09/μl (0.05-0.82);... The formation and early resolution of DVT are characterized by inflammation and endothelial/platelet activation. We have identified possible novel biomarkers such as CEC, EPC and fractalkine for the d...

Risk Factors for Postoperative Pneumonia: A Case-Control Study.

Postoperative pneumonia is a preventable complication associated with adverse outcomes, that greatly aggravates the medical expenses of patients. The goal of our study is to identify risk factors and ... A matched 1:1 case-control study, including adult patients who underwent surgery between January 2020 and June 2020, was conducted in the Second Affiliated Hospital of Kunming Medical University in Ch... Out of 17,190 surgical patients, 264 (1.54%) experienced postoperative pneumonia. Increased age, chronic obstructive pulmonary disease, emergency surgery, postoperative reduced albumin, prolonged vent... Postoperative pneumonia is associated with severe clinical outcomes. We identified six independent risk factors that can aid in risk stratification and management of patients at risk of postoperative ... www.chictr.org.cn, identifier: chiCTR2100045986....

Significance of temperature in antimuscarinic toxicity: a case-control study.

Antimuscarinic toxicity can result in temperature dysregulation, but the clinical significance of this is unclear. The objective of this study was to compare peak temperatures between antimuscarinic p... This was a case-control analysis at two large, urban, academic medical centers from January 1, 2016, through December 31, 2021. We compared peak temperature (... Fifty-six patients met inclusion criteria of which 23 developed severe outcomes: 16 seizures, 9 cases with hypotension, 5 intubations, and 2 ventricular dysrhythmias. Tmax amongst all patients ranged ... Maximum temperatures did not differ between patients with and without severe outcomes in the setting of antimuscarinic toxicity, and temperature was poorly predictive of outcomes. Our findings suggest...

A postmortem case control study of asbestos burden in lungs of malignant mesothelioma cases.

Asbestos lung content is regarded as the most reliable tool for causal attribution of malignant mesothelioma (MM) to previous asbestos exposures. However, there is a lack of studies on asbestos burden... Asbestos lung content has been assessed on formalin-fixed lung fragments using scanning electron microscopy coupled with energy dispersion spectroscopy (SEM-EDS) on individuals deceased from MM (cases... Asbestos and asbestos bodies (ABs) were found, respectively, in 73.7% and 43.2% of cases and in 28 and 22% of controls; in MM cases the most represented asbestos types were crocidolite and amosite, wh... The results suggest a correlation between asbestos burden in lungs and MM risk. The different concentration of chrysotile, as well as the different width of asbestos fibers in MM males and females mig...

Anemia and Idiopathic Intracranial Hypertension: A Case-Control Study.

Idiopathic intracranial hypertension (IIH) is a condition that mostly affects obese women of childbearing age but has been reported to be temporally related to new diagnoses of anemia. Despite these r... Consecutive IIH patients were recruited from neuro-ophthalmology clinics and matched by age and sex to consecutive patients attending neuro-ophthalmology clinics with diagnoses other than IIH. Complet... One hundred twenty-three IIH patients and 113 controls were included in the study. More IIH patients than controls had anemia (22.8%, 28/123 vs 10.6%, 12/113, P = 0.01) with an odds ratio of 2.48 (95%... Idiopathic intracranial hypertension patients have a higher prevalence of anemia compared with non-IIH neuro-ophthalmology patients. The anemia was mostly mild and may be explained by other factors re...

Study on the association between adverse drug reactions to opioids and gene polymorphisms: a case-case-control study.

Adverse drug reactions (ADRs) caused by opioid drugs show individual differences. Our objective was to explore the association between gene polymorphism and ADRs induced by opioid drugs.... Evidence-based medical data analysis was conducted for genes related to ADRs induced by opioid drugs to select target genes. Sixty patients with cancer pain who had ADRs after taking opioid drugs (mor... Based on a database search and evidence-based medical data, we identified CYP2D6*10, CYP3A5*3, ABCB1, and OPRM1 as target genes for detection. The results of statistical analysis showed no significant... Polymorphism of ABCB1 (062rs1045642) is related to ADRs caused by oxycodone, and the incidence of ADRs is higher with the allele T. Polymorphism of ABCB1 is expected to become a clinical predictor of ...

Systemic hormone therapy and dementia: A nested case-control and co-twin control study.

The effect of systemic hormone therapy (HT) on dementia risk is unclear. Our aim was to investigate the association between HT and dementia.... This register-based study consists of a nested case-control study and a co-twin control design, which controls for familial confounding, including shared genetics.... Through Danish national registries from 1995 to 2011, we identified: a) 2700 female singletons with incident dementia and 13,492 matched controls; b) 288 female twins with incident dementia and co-twi... The odds ratio (OR) for the association between systemic HT and dementia was 1.05, 95% CI = [0.93-1.19] in singletons and 2.10, 95% CI = [0.99-4.46] in twins. A statistically significant association w... Using Danish nationwide registries and controlling for education and for familial factors in a subsample, systemic HT was found to be associated with increased dementia risk if used before 2003, when ...